Cart
sales@molnova.com
Azido-PEG1-azide
CAS No. 24345-74-2
Azido-PEG1-azide( —— )
Catalog No. M24118 CAS No. 24345-74-2
Azido-PEG1-azide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 28 | In Stock |
|
| 25MG | 29 | In Stock |
|
| 50MG | 38 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAzido-PEG1-azide
-
NoteResearch use only, not for human use.
-
Brief DescriptionAzido-PEG1-azide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
-
DescriptionAzido-PEG1-azide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs
-
In VitroPROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
-
In Vivo——
-
Synonyms——
-
PathwayPROTACs
-
TargetPROTAC
-
RecptorPEGs
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number24345-74-2
-
Formula Weight156.15
-
Molecular FormulaC4H8N6O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[N-]=[N+]=NCCOCCN=[N+]=[N-]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562.
molnova catalog
related products
-
Methyltetrazine-PEG5...
Methyltetrazine-PEG5-NHS ester is a PROTAC linker belonging to the group of PEGs and is used for the synthesis of PROTAC molecules.
-
VZ185
VZ185 (VZ-185) is a potent, fast and selective, VHL-based dual degrader probe (PROTAC) of BRD9 and BRD7 with DC50 of 1.8 and 4.5 nM, respectively.
-
JH-XI-10-02
JH-XI-10-02 is a CDK8 PROTAC based on the CDK8 inhibitor JH-VIII-49, induces partial degradation of CDK8 in Jurkat cells with IC50 of 159 nM.
